Acute Care Open 3 , e000219 (2018)
The seven drugs that are currently considered GLP-1 receptor agonists include: Dulaglutide (Trulicity) Tirzepatide (Mounjaro, Zepbound) Exenatide extended-release (Bydureon) Exenatide (Byetta) Semaglutide injection (Ozempic, Wegovy) Semaglutide tablet (Rybelsus) Liraglutide (Victoza, Saxenda) Lixisenatide (Adlyxin) If all of these drugs influence GLP-1 in similar ways, what makes each of them unique
Diabetologia 47 , 15921601 (2004)
Researchers may also compare the retatrutide category with other peptides for weight loss research when evaluating investigational compounds
Kohn said there has long been a debate in gene therapy about whether it should be used for non-disease treatment, such as enhancement of height or muscle mass
Vollmer K, Holst JJ, Baller B, et al